Evofem Biosciences, Inc. [EVFM] - equity issuance
Evofem Biosciences, Inc. has filed for an equity issuance as an emerging growth company, with no specific financial terms disclosed in the filing excerpt.
Why this matters
Evofem Biosciences, Inc., a pharmaceutical company based in Delaware, focuses on developing and commercializing innovative products in the women's health sector. The company has filed for an equity issuance as an emerging growth company, indicating a strategic move to raise capital, although specific financial terms were not disclosed in the filing. This action involves an amendment to a Securities Purchase Agreement with Adjuvant Global Health Technology Fund, L.P., and Adjuvant Global Health Technology Fund DE, L.P., effective October 9, 2026.